Many know me as “Anthony the writer”. Many doctors and clinics and labs know me as “Anthony the theorist”. Actually a more apt moniker might be “Anthony the behind the scenes guy” as so much of my work is on behalf of companies and individual docs who pay to get my ideas and handiwork and affix their name to it without any mention of my authorship. All this ghostwriting, ghost-editing and ghost-theorizing has helped carve out a niche for me as, well,…a living, breathing ghost (The working world’s invisible man).
However, some of the ventures and projects I am involved with can now be divulged albeit sans key details that could be ripped off and exploited by corporate competition aka money grubbing predators and scavengers.
Amyotrophic Lateral Sclerosis (ALS): Like cancer ALS is a hellacious nut to crack on all kinds of levels. However, evidence has emerged that suggests the disease is influence by aberrant proteins called prions and disease progress reflects the spread of these prions in the central nervous system (CNS). As part of my consultancy work for Nova Cells Institute of Mexico I crafted an experimental combination drug and nondrug anti-prion regimen which was entrusted to NCIM’s affiliated MDs (which they then approved and began using). This plus NCIM’s proprietary primed stem cells and unique cytokine-protein intravenous product dubbed “Beacon Factor” has, since 2009, slowed progression to a crawl in many treated ALS patients and has so far spared all of those treated from compromised respiratory functioning. Of the handful who have died all of them simply went to sleep one night and didn’t wake up (“A good death” in many people’s book).
One ALS patient’s neurology team at Duke University commented that “Whatever these Nova Cells people have come up with seems to be working. They know their business”.
Atherosclerosis (Arterial blockage): The challenge of reversing arterial blockage has intrigued and engaged me since the mid-1980s. In fact, back then I was working with a Tibetan herbal formula called PADMA 28 that had accumulated evidence (from lab studies and also randomized clinical trials) that it significantly reduced players in the arterial plaque-building process. I was, in fact, so impressed by the science that I approached the company that had brought PADMA 28 into the USA from Switzerland (where it is Swiss FDA approved to treated intermittent claudication), Berkley Health Network (BHN – later sold and reborn as Pacific BioLogic, Inc.), and began sharing ideas concerning other applications and experimental uses. It didn’t take long before their principle technical people asked me to serve as a scientific advisor which I did. Later I did experiments in which I took a large group of guinea pigs and divided them into 2 groups: Both ate a high saturated & trans fat rich diet geared to produce artery clogging diet which resulted in significant arterial blockage. However, one also was given PADMA 28 in their chow which eventually reversed their blockage. It did this, I think, because it dropped serum lipids and triglycerides so low that their bodies began mobilizing fats and such from their arterial plague. It also countered arterial and systemic inflammation which is a player in the plaque-building process.
In the years since I have added dietary and other measures to the PADMA 28 (now marketed as PADMA BASIC®) to increase plague reversal. Since I am not a physician and cannot diagnose or prescribe treatments, I have entrusted my ever-evolving ideas & resulting regimens to licensed MDs and DOs for their discretionary use. What has emerged is simply this: Many cases have accrued in which people with significant arterial blockage have demonstrated reversal to the point whereby angina and other symptoms ceased.
Note bene: I have no commercial interest in PADMA in any of its incarnations nor in any firm or such that markets or sells it.
Cancer especially advanced metastatic malignancy: Back in 1999 Wake Forest University researcher Zheng Cui, MD, PhD showed that there are super cancer-fighting immune cells called granulocytes in young animals that could obliterate cancer in old ones (mice). Borrowing a page from Dr. Cui’s animal work I created a regimen in which I proposed that pooled granulocytes isolated from the blood of young folks would be given daily to advanced cancer patients over a 10 to 14 day period (But given only to those who have exhausted conventional cancer fighting treatments and whose cancer is spreading and is predicted to end their lives in short order).
This approach was entrusted to a group of Mexican hematologists including one of the leading ones in all of Mexico and was approved for experimental clinical use (with the number of granulocytes and the frequency of their infusions to follow a strict protocol I worked out). The types of cancer subsequently treated included prostate, breast, lung, stomach and colorectal.
There is a <1% risk of a graft v. host reaction even months after a treatment cycle is concluded which all the patients doing it were informed of as part of informed consent.
To-date all advanced, end stage cancer patients treated have responded favorably with no graft v. host reactions occurring at all. Half of those treated experienced partial remission and half, full remission. Some have been technically cancer free for many, many years now.
Eczema: Back in the early 1990s J.I. Harper, MD at the Hospital for Sick Children in London, England put an ancient Chinese herbal eczema tea to the test in a double-blind placebo-controlled clinical involving children with eczema. The tea produced a tremendous diminution in itching, pustules, and scales, for example, while the children who sipped the placebo tea (the control group) did not significantly improve.
The herbs in the eczema tea were published but not the amounts of each. I decided to figure out this out carry out my own line of research. I recruited a large number of eczema patients – children, adolescents, and adults – mixed together the botanicals in varying proportions, and then gave out various versions. (Unlike the London study, however, I opted to use an encapsulated form as opposed to a foul-tasting tea).
It took over two years working at it part-time to arrive at the most effective combination for managing eczema, but effective it is! (My results paralleled those seen in the London-based clinical trials). And it’s not effective for eczema, but for other conditions in which certain species of free radicals and highly inflammatory substances called leukotrienes and prostaglandins play a role. The conditions which have shown a significant response to the eczema formula include asthma, emphysema, psoriasis, certain rheumatic conditions, and numerous neurological maladies.
I turned over the Eczema or E-Tea formula to a company I was consulting for at the time, Prestige Chinese Teas, in 1993. I’d known and collaborated with PCT founder and President Sunny Wong since 1986 and knew he’d so all he could to get E-Tea into the hands of medical consumers at a cost they could afford, which he did. I did not ask for and ever received any proceeds from the sale of E-Tea (as I did not want to add to its cost by doing so) and ceased to be paid as a consultant for PCT in 1999 when I left the USA to teach in Japan. As I anticipated, PCT has continued to make E-Tea available at a cost that is kind to consumer purse strings: http://www.teastohealth.com/skin.html
Sunny and his people have received many, many letters and statements from eczema patients, nurses and dermatologists down through the years attesting to E-Tea’s efficacy.
There are many more vexing medical challenges I have tackled down through the years (as a theorist) and a whole litany of them which has been placed on my plate by doctors, companies and even sufferers seeking answers that I am currently working on. And while I “live and move and have my being” for the most part in the Shadowlands you may come across my solutions down the line — albeit you likely will not know I am behind it.
© 2014 by Anthony G. Payne. All rights reserved.
In 1985 a violent spring storm that swept Dallas (Texas) blew a baby bird out of its nest in an oak tree near my home and into my life. I raised this orphaned featherless descendant of the dinosaurs but had no idea what species he belonged to. Not, that is, until he feather up and it became evident he was a European starling. This was thrilling to me because I was aware of the fact that starlings are mimics like Myna birds. With this in mind I began feeding the bird, now named “Calypso,” certain words and whistled fragments of songs along with his mealworms and Myna pellets.
Around the third month after his “adoption” Calypso began whistling “Beethoven’s Fifth” and proclaiming, “I’m Calypso, I’m a big baby boy” and “Feed me, I’m hungry.”
What intrigued me was the fact Calypso used language in context and created syntactically correct new sentences. Many years later Cornell ornithologists published research detailing how they had formally documented the same faculty in these highly intelligent birds.
Later on, I performed experiments in which I took baby starlings, raised them and exposed them to Calypso and his language (while remaining mum myself.) As I anticipated these birds readily picked up Calypso’s tunes and language, and then taught them to their offspring!
Calypso, of course, became “family” to me. So much so, in fact, I took him with me when I visited family and also when I traveled to job-related projects. For instance, while working in an Ag lab and greenhouse complex near Lincoln, Nebraska during 1994-5 Calypso was there with me singing and talking to the amusement of colleagues and others who worked in the lab or came by to hang out.
In 1992 I launched the “North American Starling Fancier’s Society” to help bring together others who kept starling as pets. More than 100 people ultimately signed up. The premier issue of the NASFA newsletter follows below.
By 1995 my home aviary in Dallas had grown from a handful of birds to over 70 including not only starlings but Gouldian finches (Australian), Orange Cheek Waxbills (Africa), Cordon Bleus (Africa), Indian Ringnecks, cockatiels, Bengalese finches, and a host of others. This living laboratory not only taught me a great deal about bird behavior and their native intelligence but also afforded me the opportunity to develop a wide variety of bird nutrition mixes and medicines. I must have done something very right because my birds enjoyed extraordinary health and virtually all of them lived longer than what was published of “birds of like feather” in captivity. As best I could determine Calypso actually lived longer than any pet starling in recorded history.
NASFA as well as my once vast aviary lies in the past though my passion for birds has not diminished one iota with the passage of the years. Not surprisingly my ears perk up every time I hear a starling squawking from a power line or tree or come across a YouTube video of a pet starling singing and talking to beat the band.